Sign up United Kingdom
Proactive Investors - Run By Investors For Investors

Netflix downgraded by UBS as explosive share growth dims analyst's view

Still, the analyst remains constructive on the web-streamer's long-term business prospects and lifted his price target
Netflix display on a tablet
Netflix is set to post second-quarter earnings Monday

UBS analyst isn't as chill about Netflix (NASDAQ:NFLX) as he used to be, lowering his rating on the shares to Neutral from Buy.

In a research note to investors that appeared on, Eric Sheridan cited the explosive rise in Netflix's share price, which has more than doubled this year, as the reason behind the downgrade.

“We believe Netflix’s core competencies in both content & tech should drive a virtuous circle of greater sUBScriptions and increased viewing time, broadening its moat for global leadership in sUBScription video-on-demand firms,” wrote Sheridan.

Read: Netflix trials new ‘Ultra’ subscription plan in Europe

“It’s all priced in," he explained. "While we remain constructive on the business long-term, we view the stock as a less compelling (& roughly equal) risk/reward at current levels, pricing in 5 years of excellent forward operating performance while likely underestimating risk factors from competition, free cash flow burn, and dependence on capital markets for content spending goals.”

But the view isn't entirely pessimistic, as Sheridan did lift his price target on Netflix shares to US$425 from US$375, according to published reports.

Netflix is set to post second-quarter earnings Monday.

Shares were flat in morning trade at US$415.34.

View full NFLX profile View Profile

Netflix Timeline

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use